Journal of Cancer Research and Clinical Oncology

Journal of Cancer Research and Clinical Oncology OnlineFirst articles

26.02.2020 | Original Article – Cancer Research

Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics

Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer (Siegel et al. 2018 ), which has the highest morbidity and mortality among all cancer types (Chen et al. 2016 ; Siegel et al. 2015 ). Given the intrinsic heterogeneity and …

24.02.2020 | Original Article – Clinical Oncology

Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer

Lung cancer accounted for 13% of new cancers in 2019 and for 23% of all cancer deaths (Siegel et al. 2019 ). The disease is 2–3 times more common in individuals over 70 years, and so the incidence rate is expected to increase with population aging …

22.02.2020 | Original Article – Cancer Research

Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer

Lung cancer is recognized as the most common cancer, with a high incidence and mortality rate in the world (Torre et al. 2016 ). It nearly perpetually has a poor prognosis, and it is the most consistent reason for lung cancer-related deaths (1.6 …

22.02.2020 | Original Article – Clinical Oncology

Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung

Invasive mucinous adenocarcinoma (IMA) of the lung is a variant of adenocarcinoma characterized by a goblet or columnar cell morphology with abundant intracytoplasmic mucin.(Travis et al. 2011 , 2015a ) IMA was newly classified as a variant of …

22.02.2020 | Original Article – Clinical Oncology Open Access

Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study

Thirty-to-sixty percent of colorectal cancer patients develop liver metastases (Hugen et al. 2014 ), of which only 15–20% are resectable at presentation (Datta et al. 2019 ). Neoadjuvant chemotherapy and improvements in surgical resection criteria …

PDF-Version jetzt herunterladen Zum Volltext

Weitere Informationen

Titel

Journal of Cancer Research and Clinical Oncology

Verlag

Springer Berlin Heidelberg

Abdeckung

Volume 123/1997 - Volume 146/2020

Print ISSN

0171-5216

Elektronische ISSN

1432-1335

DOI

https://doi.org/10.1007/432.1432-1335

Zeitschriften-ID

432